Connection

JENNIFER WARGO to Tumor Suppressor Protein p53

This is a "connection" page, showing publications JENNIFER WARGO has written about Tumor Suppressor Protein p53.
Connection Strength

0.160
  1. Gut Microbes' Impact on Oncogenic Drivers: Location Matters. Mol Cell. 2020 09 17; 79(6):878-880.
    View in: PubMed
    Score: 0.075
  2. Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients. Cancer. 2017 04 15; 123(8):1372-1381.
    View in: PubMed
    Score: 0.058
  3. Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. Mol Cancer Ther. 2016 10; 15(10):2442-2454.
    View in: PubMed
    Score: 0.014
  4. Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations. J Cutan Pathol. 2015 May; 42(5):308-17.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.